CORE LABORATORIES N.V. SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
CORE LABORATORIES N.V. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of -$1.01 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2023-02-10
- CORE LABORATORIES N.V. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2022 was -$1.01M.
- CORE LABORATORIES N.V. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2021 was -$588.00K.
- CORE LABORATORIES N.V. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2020 was -$650.00K.
- CORE LABORATORIES N.V. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2019 was -$454.00K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|
| 2022-12-31 | -$1.01M 10-K · filed 2023-02-10 |
| 2021-12-31 | -$588.00K 10-K · filed 2023-02-10 |
| 2020-12-31 | -$650.00K 10-K · filed 2023-02-10 |
| 2019-12-31 | -$454.00K 10-K · filed 2022-02-10 |
| 2018-12-31 | -$560.00K 10-K · filed 2021-02-08 |
| 2017-12-31 | -$428.00K 10-K · filed 2020-02-10 |